ASH 2025: Myelofibrosis Roundup

1. Ruxolitinib is the standard initial treatment for myelofibrosis. 2. Combination therapy with pelabresib shows promising results. 3. Elritercept aids in anemia management associated with MF. 4. Real-world studies show long-term effectiveness of ruxolitinib. 5. Stem cell transplant is the only curative option for high-risk patients.